Copyright
©The Author(s) 2022.
World J Clin Cases. Mar 26, 2022; 10(9): 2773-2782
Published online Mar 26, 2022. doi: 10.12998/wjcc.v10.i9.2773
Published online Mar 26, 2022. doi: 10.12998/wjcc.v10.i9.2773
Figure 2 Dose-response of the series of successful and unsuccessful moderate sedation.
In total, 28 out of 30 sedations were successful in ensuring MOAA/S ≤ 3. ● Indicates success. ○ Indicates failure. IN SUF: Intranasal sufentanil.
- Citation: Zou Y, Li N, Shao LJZ, Liu FK, Xue FS, Tao X. Determination of the ED95 of intranasal sufentanil combined with intranasal dexmedetomidine for moderate sedation during endoscopic ultrasonography. World J Clin Cases 2022; 10(9): 2773-2782
- URL: https://www.wjgnet.com/2307-8960/full/v10/i9/2773.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i9.2773